Prilenia Company
Prilenia is a clinical-stage biotech company that develops novel treatments for neurodegenerative and neurodevelopmental disorders.
Technology:
Small Molecules
Industry:
Geroscience
Headquarters:
Herzliya, Tel Aviv, Israel
Founded Date:
2018-01-01
Employees Number:
11-50
Investors Number:
8
Total Funding:
105500000
Estimated Revenue:
Less than $1M
Last Funding Date:
2021-11-03
Last Funding Type:
Series B
Register and Claim Ownership